Zanubrutinib
Price | Get Latest Price | ||
Package | 1g | 5g | 10g |
Min. Order: | 1g |
Supply Ability: | 1000 |
Update Time: | 2025-01-17 |
Product Details
Product Name: Zanubrutinib | CAS No.: 1691249-45-2 |
Min. Order: 1g | Purity: 98 |
Supply Ability: 1000 | Release date: 2025/01/17 |
Product Name: Zanubrutinib
Synonyms: Zanubrutinib;anubrutinib;BGB-3111(Zanubrutinib);The BTK inhibitor;Zanubrutinib (BGB-3111);BGB-3111;ZANUBRUTINIB;BGB 3111;BGB3111;(S)-7-(1-Acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide;Pyrazolo[1,5-a]pyrimidine-3-carboxamide, 4,5,6,7-tetrahydro-7-[1-(1-oxo-2-propen-1-yl)-4-piperidinyl]-2-(4-phenoxyphenyl)-, (7S)-
CAS: 1691249-45-2
MF: C27H29N5O3
MW: 471.55
Zanubrutinib, a second-generation BTK inhibitor discovered and developed by BeiGene in China, has been approved by the FDA (in 2019) for treating chronic lymphocytic leukemia (CLL) and certain other indications. Zanubrutinib has lower toxicity and better efficacy than ibrutinib. It is in direct competition with AstraZeneca’s acalabrutinib for the $12 billion blood cancer market currently dominated by the first-in-class BTK inhibitor ibrutinib.
Company Profile Introduction
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$57.00/1mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2024-11-19 | |
$0.00/1g |
VIP1Y
|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
|
2024-08-09 | |
$0.00/1g |
VIP5Y
|
Jinan Jianfeng Chemical Co., Ltd
|
2024-05-28 |
- Since: 2024-03-12
- Address: Room 02-31, 13 / F, Building 9, Guannan Fuxing Medical Park Phase II, No.58, Guanggu Avenue, East La